Citing potential disclosure requirements from the Food and Drug Administration, lack of insurance coverage and lack of support among clinicians, the founders of stool-donation initiative, OpenBiome, ...
DEAR DR. ROACH: I am a 76-year-old male who is in relatively good health. For the past six months, I have been experiencing diarrhea on and off. I initially spoke to my general physician, and he ...
A new Cochrane Review led by an Upstate Medical University professor has found that, compared with standard antibiotic treatment, stool transplantation can increase the number of people recovering ...
Fecal microbiota transplantation has become one of the most effective treatments for recurrent Clostridioides difficile infections, but its long-term role in gastroenterology may hinge on moving ...
When I took antibiotics for a sinus infection, I began feeling weak and feverish, with diarrhea. I went to the ER and learned I had Clostridioides difficile, an infection in the large intestine. The ...
Harvard researchers make the case for people storing their poop when young, in order to restore their gut microbiomes later in life. Reading time 3 minutes Experts at Harvard and elsewhere are ...
Scientists at the Public Health England’s laboratory at Heartlands Hospital in Birmingham, U.K., are claiming a 90 percent success rate for C. diff patients treated with fecal transplants after ...
Clostridium difficile bacteria, computer illustration. C. difficile is a normal inhabitant of the human intestine, but it can become a pathogen when antibiotics disrupt the normal intestinal flora and ...
There are trillions of bacteria that live in your colon. Most of them are harmless and many are actually helpful, supporting digestion and keeping your immune system strong. C. diff is one type of ...
An oral, investigational live biotherapeutic product containing eight strains of commensal Clostridia prevented recurrent Clostridioides difficile infections in a randomized, double-blind phase II ...
Vedanta Biosciences has found investors willing to bankroll its phase 3 microbiome clinical trial. While a funding freeze recently forced Finch Therapeutics to fold its rival program, Vedanta has ...
Add Yahoo as a preferred source to see more of our stories on Google. Getty Images When I took antibiotics for a sinus infection, I began feeling weak and feverish, with diarrhea. I went to the ER and ...